Ghent University Academic Bibliography

Advanced

Immunoscintigraphic detection of tumour necrosis factor by radiolabelled certolizumab pegol in patients with erosive hand osteoarthritis : a proof-of-concept study

Ruth Wittoek, Philippe Carron UGent, Bieke Lambert UGent, Paulien Meersseman, August Verbruggen UGent, Filip Van den Bosch UGent and Dirk Elewaut UGent (2017) ANNALS OF THE RHEUMATIC DISEASES.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (letterNote)
publication status
in press
subject
journal title
ANNALS OF THE RHEUMATIC DISEASES
Ann. Rheum. Dis.
ISSN
0003-4967
1468-2060
DOI
10.1136/annrheumdis-2016-210354
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
8522790
handle
http://hdl.handle.net/1854/LU-8522790
date created
2017-06-08 07:45:04
date last changed
2017-06-22 13:35:50
@article{8522790,
  author       = {Wittoek, Ruth and Carron, Philippe and Lambert, Bieke and Meersseman, Paulien and Verbruggen, August and Van den Bosch, Filip and Elewaut, Dirk},
  issn         = {0003-4967},
  journal      = {ANNALS OF THE RHEUMATIC DISEASES},
  language     = {eng},
  title        = {Immunoscintigraphic detection of tumour necrosis factor by radiolabelled certolizumab pegol in patients with erosive hand osteoarthritis : a proof-of-concept study},
  url          = {http://dx.doi.org/10.1136/annrheumdis-2016-210354},
  year         = {2017},
}

Chicago
WITTOEK, RUTH, Philippe Carron, Bieke Lambert, Paulien Meersseman, August Verbruggen, Filip Van den Bosch, and Dirk Elewaut. 2017. “Immunoscintigraphic Detection of Tumour Necrosis Factor by Radiolabelled Certolizumab Pegol in Patients with Erosive Hand Osteoarthritis : a Proof-of-concept Study.” Annals of the Rheumatic Diseases.
APA
WITTOEK, R., Carron, P., Lambert, B., Meersseman, P., Verbruggen, A., Van den Bosch, F., & Elewaut, D. (2017). Immunoscintigraphic detection of tumour necrosis factor by radiolabelled certolizumab pegol in patients with erosive hand osteoarthritis : a proof-of-concept study. ANNALS OF THE RHEUMATIC DISEASES.
Vancouver
1.
WITTOEK R, Carron P, Lambert B, Meersseman P, Verbruggen A, Van den Bosch F, et al. Immunoscintigraphic detection of tumour necrosis factor by radiolabelled certolizumab pegol in patients with erosive hand osteoarthritis : a proof-of-concept study. ANNALS OF THE RHEUMATIC DISEASES. 2017;
MLA
WITTOEK, RUTH, Philippe Carron, Bieke Lambert, et al. “Immunoscintigraphic Detection of Tumour Necrosis Factor by Radiolabelled Certolizumab Pegol in Patients with Erosive Hand Osteoarthritis : a Proof-of-concept Study.” ANNALS OF THE RHEUMATIC DISEASES (2017): n. pag. Print.